Endometrial glandular dysplasia: A putative precursor lesion of uterine papillary serous carcinoma. Part II: Molecular features

International Journal of Surgical Pathology

Volumn 12, Issue 4, 2004, Pages 319-331

  Liang, Sharon X ^a   Chambers, Setsuko K ^a   Cheng, Liang ^b   Zhang, Shaopo ^b   Zhou, Yi ^a   Zheng, Wenxin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Endometrial carcinoma; Endometrial glandular dysplasia (EmGD); Serous EIC; Uterine papillary serous carcinoma

Indexed keywords

DNA MARKER; PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOSARCOMA; CHROMOSOME IDENTIFICATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DNA EXTRACTION; ENDOMETRIAL GLANDULAR DYSPLASIA; ENDOMETRIOID CARCINOMA; FEMALE; GENE FREQUENCY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MICROSATELLITE MARKER; PAPILLARY CARCINOMA; PRIORITY JOURNAL; UTERUS CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DNA, NEOPLASM; ENDOMETRIUM; EXOCRINE GLANDS; FEMALE; GENETIC MARKERS; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MICRODISSECTION; MICROSATELLITE REPEATS; MIDDLE AGED; PRECANCEROUS CONDITIONS; UTERINE NEOPLASMS;

EID: 4043147106     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690401200405     Document Type: Article

References (55)

1. Lauchlan SC. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 105:615-618, 1981
2. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6:93-108, 1982
3. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: A study of 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47:298-305, 1992
4. Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RCJ. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol 170:246-252, 1994
5. Zheng W, Cao P, Zheng M, Kramer EE, Godwin T. p53 and bcl-2 expression in endometrial adenocarcinoma. Comparison of serous and endometrioid subtypes (see comments). Gynecol Oncol 61:167-174, 1996
6. Kovalev S, Marchenko ND, Gugliotta BG, Chalas E, Chumas J, Moll UM. Loss of p53 function in uterine papillary serous carcinoma. Hum Pathol 29:613-619, 1998
7. Niederacher D, An HX, Camrath S, Dominik SI, Gohring UJ, Oertel A, Grass M, Hantschmann P, Lordnejad MR, Beckmann MW. Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer. Eur J Cancer 34:1770-1776, 1998
8. Sirchia SM, Sironi E, Grati FR, Serafini P, Garagiola I, Rossella F, Dulcetti F, Pardi G, Garsia S, Simoni G. Losses of heterozygosity in endometrial adenocarcinomas: Positive correlations with histopathological parameters. Cancer Genet Cytogenet 121:156-162, 2000
9. Bur ME, Perlman C, Edelmann L, Fey E, Rose PG. p53 expression in neoplasms of the uterine corpus. Am J Clin Pathol 98:81-87, 1992
10. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Clarke-Pearson DL, Bast RC, Marks JR. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622-1627, 1992
11. King GI, Adas AA, Livolsi VA, Takahashi H, Behbaht K, McGovern P, Benjamin I, Rubin SC, Boyd J. Expression and mutatuion analysis of the p53 gene in uterine papillary serous carcinoma. Cancer 75:2700-2705, 1995
12. Sherman M, Bur ME, Kurman RJ. p53 in endometrial cancers and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268-1274, 1995
13. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150:177-185, 1997
14. Zheng W, Khurana R, Farahmand S, Wang Y, Zhang ZF, Felix JC. p53 immunostaining as a significant diagnostic marker for uterine surface carcinoma - precursor lesion of uterine papillary serous carcinoma. Am J Surg Pathol 22:1463-1473, 1998
15. Todesca-Bancher D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair A, Heinze G, Breitenecker G, Hacker NF. p53 Protein overexpression: A strong prognostic factor in uterine papillary serous carcinoma. Gynecologic Oncology 71:59-63, 1998
16. Sung J, Quddus M, Zheng Y, Zhang ZF, Lauchlan SC, Zheng W. p53 serves as a significant prognostic marker in endometrial carcinomas. Int J Gynecol Cancer 10:119-127, 2000
17. Ragnarsson G, Eiriksdottir G, Johannsdottir J, Jonasson J, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival. Br J Cancer 79:1468-1474, 1999
18. Arlt MF, Herzog TJ, Mutch DG, Gersell DJ, Liu H, Goodfellow PL. Frequent deletion of chormosome 1p sequences in an aggressive histologic subtype of endometrial cancer. Hum Mol Genet 5:1017-1021, 1996
19. Herzog TJ, Kowalski LD, Liu H, Arlt M, Swisher E. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma. Gynecol Oncol 82:139-142, 2001
20. Caduff RF, Newman-Svoboda S, Bartos R, Ferguson A, Frank T. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma. Am J Surg Pathol 22:319-326, 1998
21. Bandera C, Muto M, Schorge J, Berkowitz R, Rubin S, Mok S. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol 92:596-600, 1998
22. Kornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature. Gynecol Oncol 75:300-304, 1999
23. Tritz D, Pieretti M, Turner S, Powell D. Loss of heterozygosity in usual and special variant carcinomas of the endometrium. Hum Pathol 28:607-612, 1997
24. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 32:569-577, 2001
25. Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: Evidence of distinct molecular genetic pathways. Cancer 88:814-824, 2000
26. An HJ, Lee YH, Cho NH, Shim JY, Kim JY, Lee C, Kim SJ. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27. Histopathology 41:437-445, 2002
27. Sherman ME. Theories of endometrial carcinogenesis: A multidisciplinary approach. Mod Pathol 13:295-308, 2000
28. Diaz-Cano SJ, Blanes A, Wolfe HJ. PCR techniques for clonality assays. Diagn Mol Pathol 10:24-33, 2001
29. Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 55:490-492, 1995
30. Shenson DL, Gallion HH, Powell DE, Pieretti M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 76:650-657, 1995
31. Fujita M, Enomoto T, Wada H, Inoue M, Okudaira Y, Shroyer KR. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol 105:350-359, 1996
32. Fujii H, Matsumoto T, Yoshida M, Furugen Y, Takagaki T, Iwabuchi K, Nakata Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M, Hirose S, Shirai T. Genetics of synchronous uterine and ovarian endometrioid carcinoma: Combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability. Hum Pathol 33:421-428, 2002
33. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274:2057-2059, 1996
34. Cheng L, Bostwick DG, Li G, Wang Q, Hu N, Vortmeyer AO, Zhuang Z. Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 85:2017-2022, 1999
35. Takamochi K, Ogura T, Suzuki K, Kawasaki H, Kurashima Y, Yokose T, Ochiai A, Nagai K, Nishiwaki Y, Esumi H. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol 159:1941-1948, 2001
36. Maitra A, Wistuba I, Washington C, Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF, Minna JD. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 159:119-130, 2001
37. Maitra A, Gazdar AF, Moore TO, Moore AY. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: Laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi. Hum Pathol 33:191-197, 2002
38. Mutter GL, Baak JP, Crum CP, Richart RM, Ferenczy A, Faquin WC. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 190:462-469, 2000
39. Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE. Endometrial glandular dysplasia, a putative precursor lesion of uterine papillary serous carcinoma: A morphological study. Intl J Surg Pathol 12:207-223, 2004
40. Kurman RJ, Zaino RJ, Norris HJ. Endometrial carcinoma. In Blaustein's Pathology of the female genital tract, Kurman RJ (ed), 4th ed. Springer-Verlag, New York, pp 439-486, 1994
41. Dillon DA, Zheng K, Costa J. Rapid, efficient genotyping of clinical tumor samples by laser-capture microdissection/PCR/SSCP. Exp Mol Pathol 70:195-200, 2001
42. Gu J, Roth LM, Younger C, Michael H, Abdul-Karim FW, Zhang S, Ulbright TM, Eble JN, Cheng L. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. [see comments]. J Natl Cancer Inst 93:1147-1152, 2001
43. Cheng L, Song S-Y, Pretlow TG, Abdul-Karim F, Kung H-J, Dawson DV, Park W-S, Moon Y-W, Tsai M-L, Linehan M, Emmert-Buck MR, Liota LA, Zhuang Z. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 90:233-242, 1998
44. Jass JR, Barker M, Fraser L, Walsh MD, Whitehall VL, Gabrielli B, Young J, Leggett BA. APC mutation and tumour budding in colorectal cancer. J Clin Pathol 56:69-73, 2003
45. Peiro G, Diebold J, Lohse P, Ruebsamen H, Lohse P, Baretton GB, Lohrs U. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. Hum Pathol 33:347-354, 2002
46. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 55:467-471, 1995
47. Caduff RF, Svoboda-Neumann SM, Johnston CM, Bartos RE, Frank TS. Molecular analysis in endometrial cancer. Verh Dtsch Ges Pathol 81:219-227, 1997
48. Weinberg RA. Tumor suppressor genes. Science 254:1138-1146, 1991
49. Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LH, Friedlander ML. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: Evidence suggestive of the linear progression model. Br J Cancer 83:729-736, 2000
50. Luttges J, Galehdari H, Brocker V, Schwarte-Waldhoff I, Henne-Bruns D, Kloppel G, Schmiegel W, Hahn SA. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158:1677-1683, 2001
51. Guo Z, Hu X, Afink G, Ponten F, Wilander E, Ponten J. Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer. Intl J Cancer 86:518-523, 2000
52. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 26:1260-1267, 1995
53. Lavie O, Kornreich G, Arie AB, Renbaum P, Levy-Lahad E, Beller U. BRCA-1 germline mutations in women with uterine serous papillary carcinoma. Obstet Gynecol 96:28-32, 2000
54. Miturski R, Bogusiewicz M, Ciotta C, Bignami M, Gogacz M, Burnour D. Mismatched repair genes and microsatellite instability as molecular markers for gynecological cancer detection. Exp Biol Med (Maywood) 227:579-586, 2002
55. Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE. Endometrial glandular dysplasia: A newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. IJSP 12:207-223, 2004